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functional ambulation after total knee arthroplasty
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Background: The Six-minute walk (6MW) and Timed-Up-and-Go (TUG) are short walk tests commonly used to
evaluate functional recovery after total knee arthroplasty (TKA). However, little is known about walking capacity of
TKA recipients over extended periods typical of everyday living and whether these short walk tests actually predict
longer, more functional distances. Further, short walk tests only correlate moderately with patient-reported
outcomes. The overarching aims of this study were to compare the performance of TKA recipients in an extended
walk test to healthy age-matched controls and to determine the utility of this extended walk test as a research tool
to evaluate longer term functional mobility in TKA recipients.
Methods: The mobility of 32 TKA recipients one year post-surgery and 43 healthy age-matched controls were
assessed using the TUG, 6MW and 30-minute walk (30MW) tests. The latter test was repeated one week later.
Self-reported function was measured using the WOMAC Index and a physical activity questionnaire.
Results: 30MW distance was significantly shorter amongst TKA recipients (mean 2108 m [95% CI 1837 to 2381 m];
Controls 3086 m [2981 to 3191 m], P < 0.001). Test-retest repeatability was high (ICC = 0.97, TKA; 0.96, Controls).
Amongst TKA recipients, the 30MW distance correlated strongly with the shorter tests (6MW, r = 0.97, P < 0.001;
TUG, r = −0.82, P < 0.001). Multiple regression modeling found 6MW distance to be the only significant predictor
(P < 0.001) of 30MW distance, explaining 96% of the variability. The TUG test models were moderate predictors of
WOMAC function (55%) and physical activity (36%) and were stronger predictors than 6MW and 30 MW tests.
Conclusions: Though TKA recipients are able to walk for 30 minutes one year post-surgery, their performance falls
significantly short of age-matched norms. The 30MW test is strongly predicted by 6MW test performance, thus
providing strong construct validity for the use of the 6MW test in the TKA population. Neither a short nor long walk
test is a strong predictor of patient-reported function after TKA.
Keywords: Gait, Self-reported outcomesBackground
Maximizing functional mobility is a key goal of rehabili-
tation after total knee arthroplasty (TKA) surgery. The
Timed-Up-and-Go (TUG) and Six-minute walk (6MW)
tests are commonly used to evaluate functional recovery
after TKA [1-9] as they are simple to administer and re-
liable [5,10]. However, for research demonstrating long-
term functional recovery after TKA an extended walk
test may be more useful as an outcome measure for sev-
eral reasons. Firstly, little is known about walking ability* Correspondence: vwmko@yahoo.com
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reproduction in any medium, provided the orbeyond six minutes amongst TKA recipients. At 12
months or more after surgery, when functional perform-
ance is considered close to optimum, TKA recipients
may wish to walk for longer duration for fitness or occu-
pational needs. As such, a longer walk test can provide
insight into ambulatory capacity over a more functional,
everyday duration, and therefore, have greater face valid-
ity. Secondly, by extension, if a longer test approximates
true functional requirements more than a shorter test, it
may have a stronger correlation with self-reported be-
haviors than that associated with the shorter walk tests.
The TUG and 6MW tests have been shown to have only
moderate correlations at best with measures of self-
reported function after TKA [11,12] and with physicalThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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suggesting that self-reported function tools and timed
mobility tests measure different aspects of function [4].
Consequently, both forms of assessment are considered
necessary post-surgery. We contend, therefore, if an ex-
tended mobility test has greater correlation with per-
ceived function simply because it may be more
‘functional’, then the extended walk could be a close
proxy for self-reported function (or vice versa). Thirdly,
a longer walk test may be useful in discriminating be-
tween individuals because it is likely that not every indi-
vidual can maintain the fast paced walking achieved in
the 6MW test over a longer period. It is possible that in-
dividuals who appear comparable on a short duration
walk test exhibit fatigue and differences in walking en-
durance beyond six minutes of walking.
The use of extended walk tests has been investigated
in other populations. In a study of the two-, six-and 12-
minute walk tests in patients following stroke, the 12-
minute walk test was observed to be the most responsive
to change [14]. Further, despite high correlation between
the three tests, the two-minute assessment was reported
to overestimate 6 and 12 minute walking distances. The
authors suggested the overestimation may be due to fa-
tigue during the longer tests. In another study investigat-
ing patients with stable chronic airflow obstruction, a
12-minute walk test was also found to be highly corre-
lated to six-minute and two-minute walk tests [15]. Vari-
ance of the 12-minute walk test was greater than the
shorter walk tests, suggesting that the longer test was
perhaps more discriminating. However, as the shorter
walk tests were easier for both the patient and re-
searcher, the authors recommended the six-minute walk
as a fair compromise. Compared to other patient popu-
lations, TKA recipients may be affected by different fac-
tors which limit walking capacity, such as residual knee
pain and reduced muscle strength. As such, it cannot be
assumed that the results of these studies can be general-
ized to the TKA population.
To date, there has been no examination of the utility
of a walking test beyond six minutes in the TKA popula-
tion. The overarching aim of this study was to determine
the utility of an extended walk test as a research tool to
evaluate longer-term functional mobility in TKA recipi-
ents. The specific aims of the study were multiple: 1) to
assess the performance and repeatability of the extended
test in TKA recipients one year after surgery and in
healthy age-matched controls; 2) to examine the correla-
tions between the extended walk test and both the TUG
and 6MW tests amongst the TKA cohort; 3) to deter-
mine the predictors of performance of the extended walk
test amongst the TKA cohort; and finally, 4) to examine
which of the walk tests best predicts self-reported func-
tion and physical activity. The main hypotheses to beaddressed were that: TKA recipients one year post-
surgery will perform significantly worse than age-
matched healthy controls in an extended walk test; the
shorter walk tests will not predict performance in the
longer walk test, and; the longer walk test will be a
stronger predictor of self-reported function and physical
activity than the shorter walk tests.
Methods
Prior to undertaking the definitive study, a pilot survey of
patients awaiting knee and hip replacement was
performed to determine a time parameter for an extended
walk test which may be functionally relevant for this pa-
tient group. Sixty-four consecutive individuals [n = 47
awaiting TKA, mean age 68.3 (SD 10.7) years, 77% female;
n = 17 awaiting total hip arthroplasty, mean age 61.5 (SD
10.9), 71% female] attending the pre-operative joint re-
placement education class at a public hospital completed a
written survey comprising close-ended questions about
current and expected 1-year walk times. At the time of the
survey, 52% of participants reported a maximum walking
duration of 10 minutes or less before they had to stop due
to their leg symptoms. As anticipated, participants expected
to be able to walk much further 1-year post surgery; 86% of
participants expected to be able to walk 25 minutes non-
stop, and over 50% expected to be able to walk 50 minutes
non-stop one year post-surgery. From these data, we rea-
soned that a 30-minute walk (30MW) test was in accord-
ance with patient expectations for functional mobility one
year after TKA.
Participants
A convenience sample of a minimum of 60 subjects (30
TKA recipients and 30 age-matched healthy controls)
was planned for this study. The sample size was a com-
promise between gathering sufficient data for repeatabil-
ity and cross-sectional analyses based on what is known
from previous timed mobility trials in TKA and elderly
populations (n=22 to 51) [5,11,16,17], and the need to
test within the cooler, drier months (Autumn, Winter)
to reduce environmental confounders.
For the TKA cohort, patients who underwent TKA 12
to 18 months prior were identified from an existing hos-
pital database and a random sample was selected using a
computer-generated sequence. The selected individuals
were contacted and screened via a telephone interview.
Eligible patients were invited to participate. To improve
generalizability, patients with other co-morbidities and
other musculoskeletal pain were not excluded, as patients
who undergo TKA commonly present with multiple co-
morbidities and other joint disease [18,19]. However, the
following exclusion criteria were used to ensure patient
safety during walk test performance: unstable angina,
myocardial infarction, or cardiopulmonary, spinal or lower
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of uncontrolled hypertension; and inability to comprehend
English.
Healthy control volunteers were recruited from the
community through flyers placed in hospital grounds
and through word-of-mouth. To allow comparison with
a genuinely healthy population of this age group, volun-
teers were excluded if they had acute or chronic respira-
tory, cardiac, neurological and musculoskeletal disorders
involving significant mobility impairment. Eligibility was
determined via telephone interview.
All participants who provided written, informed con-
sent were enrolled into the trial. The protocol and con-
sent forms were reviewed and approved by the South
Western Sydney Local Health District Human Research
Ethics Committee. The characteristics of the participants
including age, gender. height, and body mass index
(BMI) are summarized in Table 1.
Experimental design
Testing took place at three outdoor sites for the conveni-
ence of the participants. An outdoor setting was used to
simulate normal functional walking conditions. Well de-
marcated, level, paved, concrete or bitumen footpaths de-
void of obstacles were chosen. Participants were tested
under dry conditions with ambient temperature between
13 to 24 degrees Celsius. Time of testing was constant for
each participant. Participants were instructed to wear sup-
portive footwear and comfortable clothing.
Resting heart rate (HR) was measured (Polar F4™ or
F6™, Polar Electro Oy, Finland) at the commencement
of the testing session. As with other studies evaluating
6MW tests [16,20], HR was monitored as an indicator of
participant effort. The average and maximum HRs
achieved, together with the time spent with HR greater
than 65% of age-predicted HR maximum, were recorded.Table 1 Subject characteristics, WOMAC scores, and physical
Age, years (mean, 95% CI)
Gender, female
Height, meters (mean, 95% CI)
BMI (mean, 95% CI)
Diagnosis of Osteoarthritis, n (%)
Number of Co-morbidities, n (median, IQR)
WOMAC Pain, max score 50 (median, IQR)
WOMAC Function, max score 170, higher score worse function (median, IQR)
Occasions of physical activity, n (median, IQR)
Total duration of physical activity, minutes (median, IQR)
Use of walking aid, n
Abbreviations:
BMI = Body mass index; CI = Confidence interval; IQR = Inter-quartile range; N = numb
Universities Osteoarthritis Index.65% of age-predicted HR maximum was used to indicate
whether a moderate level of exercise intensity had been
achieved [20,21].
Four assessors used standardized instructions to admin-
ister the tests. All subjects performed walk tests in the
same order. The TUG and 6MW tests were conducted
first. A seated rest of at least 10 minutes was given after
the 6MW test. On restoration of resting heart rate, the
participant performed the 30MW test.
Tests
TUG
The procedures for the TUG test was based on published
protocols [22]. A standard height chair of 45cm with arm
rests was placed on an outdoor level footpath, and a line 3
metres from the chair was drawn. The participant was
instructed to stand up from the chair, walk to the line,
turn around, walk back to the chair and sit down as
quickly and safely as possible. The assessor commenced
timing as the participant leaned forward to stand up, and
ceased when the participant’s hips made contact with the
seat to sit down. A minimum of two tests was performed
for each participant with the best time used in the analysis.
High repeatability of the TUG has been established in pa-
tients awaiting TKA (ICC 0.75) [23].
6MW test
The procedure for the 6MW test was based on pub-
lished guidelines [24]. A 25 metre section of the outdoor
footpath was demarcated for this test. The participant
was instructed to walk as far as possible for six minutes,
up and down the demarcated footpath, pivoting to turn
at the end of each lap. Timing commenced as the par-
ticipant stepped over the start line. Standardized encour-
agement was given to the patient after each minute. The
participant was instructed to stop at six minutes, oractivity of TKA cohort and healthy controls
TKA (n = 32) Controls (n = 43) P
66.7 (64.3 to 69.2) 65.0 (62.6 to 67.5) 0.333
56% 56%
1.67 (1.63 to 1.70) 1.66 (1.63 to1.68) 0.806
30.8 (27.6 to 34.9) 23.6 (22.2 to 27.3) <0.001
28 (87.5%) 0
2 (1 to 3) 0 (0 to 1) <0.001
4 (1.0 to 11.9) 0 (0 to 0) <0.001
22.8 (10.2 to 60.5) 0 (0 to 2) <0.001
7 (2 to 11) 9 (6.5 to 13.5) <0.001
138 (40 to 305) 390 (280 to 615) <0.001
3 0
er; TKA = Total knee arthroplasty; WOMAC = Western Ontario and McMaster
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to maintain their position whilst the assessor measured
the final partial lap with a trundle wheel. The use of a
walking aid and standing rests were permitted. One test
was performed for each participant as we did not want
fatigue from completing two 6MW tests to undermine
performance in the longer test. High repeatability of the
6MW test has been established in patients awaiting
TKA (ICC 0.94) [23].
30MW test
For the 30MW test, a 200 m section of the footpath was
demarcated. A 200 m lap was chosen as it kept the fre-
quency of turns low whilst keeping the participant in full
view of the investigator at all times. The curvature of the
path varied slightly between sites. Four subjects (three
not included in the study) performed reliability tests of
the 30MW test between the sites. Subjects varied within
5% at each site and this was considered an acceptable
level of variation given the need to be flexible with the
location of the testing site.
The participant was instructed to walk as far as pos-
sible and safely for 30 minutes along the 200 m track,
pivoting to turn at the end of each lap. Participants were
permitted to rest in standing at any time if required and
to resume walking as soon as able. Encouragement was
given by the assessor after every lap. The assessor com-
menced timing as the participant stepped over the
starting line and ceased at 30 minutes. At this point, the
participant was instructed to maintain their position on
the track while the assessor measured the distance of the
partial lap with a trundle wheel. Testing was terminated
if the participant reported that they were unable to con-
tinue and the distance covered in the abbreviated test
was recorded as the distance covered in 30 minutes. To
evaluate gait characteristics, the assessor recorded the
number of laps walked, the number of steps and time
taken during one lap in the initial five minutes and again
during the last five minutes of the test, and the number
and duration of any rests taken, noting the reasons for
resting. From this, average cadence, average step length
and total 30MW distance were calculated. To measure
test-retest reliability of the 30MW test, participants re-
peated the test within two weeks of the first test using
the same track.
Western Ontario and McMaster Universities Osteoarthritis
Index VA3.1 (WOMAC)
The WOMAC index [25] was used to measure patient-
reported pain and function. The pain and function sub-
scales of the WOMAC index were scored using a visual
analogue scale on a 10cm line for each question and a
total was calculated for each subscale (worst score 50 for
pain, 170 for function).Physical activity questionnaire
The questions on physical activity from the National
Physical Activity Survey [26], were used as the data pro-
vide a contemporary population-based comparison for
our cohort. The total number of sessions and total dur-
ation of physical activity was calculated by summating
reported sessions and duration of walking over 10 mi-
nutes, and moderate and vigorous activity.
Statistical analysis
Descriptive statistics were calculated for continuous vari-
ables, and distribution was examined. Independent t-tests
and Mann–Whitney U tests were used to compare subject
characteristics and walking test variables as appropriate.
Chi square test was used to compare difference in partici-
pants requiring rests between the groups. Paired t-tests
were used compare the difference in average walking speed
between 6MW and 30MW tests. Repeatability of the
30MW test was measured by calculating the intra-class co-
efficient (ICC) (two way random, absolute agreement).
Correlation coefficients (Pearson’s or Spearman’s rank as
appropriate) were computed between pairs of walk tests,
and multiple linear regressions were used to determine the
predictors of the 30MW test in the TKA cohort, respect-
ively. Multiple linear regression modeling was used to es-
tablish predictive models for WOMAC function score and
total time of physical activity in the TKA cohort. To com-
pare the predictive value of the three walk tests, three
models were generated for each dependent variable using
gender, body mass index (BMI), and one of the walk tests
as independent variables. Each model was limited to three
independent variables due to the sample size. These vari-
ables were determined a priori, and were selected based on
current literature [18,27-29]. Appropriate regression diag-
nostics were used in modeling. For all analyses, P < 0.05
was deemed as significant. Data from the first testing ses-
sion of the 30MW test were used in the regression
analyses.
Results
Of the 118 patients who underwent TKA surgery at our
institution between January and July 2008, 90 patients
were randomly selected and screened. Based on exclu-
sion criteria, 45 patients were eligible; 32 of these subse-
quently consented to participate. Forty-three healthy
volunteers were also screened and recruited for the
study. Subject characteristics, WOMAC pain and func-
tion scores, and weekly physical activity, are summarized
in Table 1. In the data set, there were three missing
values of TUG in the TKA cohort and one in the healthy
cohort due to administration error. Whilst age, gender
and height were similar between the TKA cohort and
controls, all other measures were significantly different
between the two groups. Performances in the TUG and
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pared to healthy controls (Table 2).
Performance and repeatability of 30MW test
TKA recipients walked significantly shorter distances, with
shorter step length and lower cadence than control sub-
jects in 30 minutes (Table 2). No participants stopped to
rest during the 6MW test. Significantly more participants
amongst the TKA cohort required rests compared to con-
trols during the 30MW test (12/32 TKA; 0/43 Controls;
p<0.001). The number of rests ranged from one to more
than ten occasions. TKA recipients reported factors which
limited their performance included pain in the index knee
(n = 5), back and other lower limb joint pain (n = 13), and
poor aerobic fitness (n=10). Control subjects had a signifi-
cantly faster walking speed in the 30MW test than the
6MW test (P < 0.001), while TKA recipients had very
similar walking speeds (P = 0.83). Subgroup analysis found
that for TKA participants who rested (n= 12), 6MW
speed was 0.90 m/s compared to 30MW speed of 0.82
m/s (P = 0.08). For TKA participants who did not rest
(n = 20), the difference between 6MW speed and 30MW
speed was minor and did not quite reach significance
(1.34 m/s vs 1.38 m/s, P = 0.05).
Both groups exerted similar effort during the test as
measured using heart rate [TKA average time with over
65% age-predicted HR maximum 26.6 minutes (SD 7.9),
mean HR 117 (SD 17) beats per minute; Control average
time 29.8 (SD 0.5) minutes, mean HR 127 (SD 13) beats
per minute]. Supplementary analysis revealed that the
30MW distance covered by the TKA cohort [mean 2360
m (SD 340), P<0.001] remained significantly lower than
the age-matched group when TKA recipients with other
conditions impairing mobility (such as symptomatic lower
limb, back or respiratory disease) (n=13) were removed.
All control subjects and 12 TKA recipients performed
a repeat test. TKA recipients were reluctant to perform
a second test as they found the test to be difficult. For
participants who performed a second test, excellent re-
peatability was observed in the distance walked as de-
noted by the very high ICCs obtained for both groups
(Table 3). Effort was also consistent between the two tests,Table 2 TUG, 6MW and 30 MW test performance, mean (95%
Walk test
TUG (TKA : n = 29, Controls: n = 42) Time, second (median, IQR) 7.4
6MW test (TKA: n = 32; Controls n = 43) Distance, meters 423.5
Speed, meters per second 1.18
30MW test(TKA n = 32; Controls n = 43) Distance, meters 2108
Average step length, meters 0.68
Cadence, steps per minute 112
Speed, meters per second 1.17
Abbreviations:
CI = confidence interval; IQR = Inter-quartile range; N = number; TKA = Total knee awith 97% of the healthy cohort and 73% of TKA partici-
pants achieving above 65% age-predicted HR maximum
for 25 minutes or more across both days. On average, dis-
tance walked was better in their second test, but the differ-
ence was only significant in controls (P = 0.006).
Correlations between 30MW test versus 6MW test or TUG,
and predictors of 30MW test performance in TKA cohort
Scatter plots of 30MW distance versus TUG and 30MW
distance versus 6MW distance for TKA patients are
shown in Figure 1. Whilst the correlation between 30MW
distance and TUG was strong (r = −0.82, P < 0.001), near-
perfect correlation was found between 30MW distance
and 6MW distance (r = 0.97, P < 0.001). Multiple regres-
sion modeling of 30MW distance using height, TUG and
6MW distance as variables found 6MW distance to be the
only significant predictor (B 5.36, 95% CI 4.42 – 6.30,
P < 0.001) of 30MW distance, with R2 of 0.96.
Prediction of self-reported function and physical activities
using walk tests
The significant predictor variables for self-reported func-
tion (WOMAC) and reported weekly duration of phys-
ical activity using multiple regression modes are shown
in Table 4. Self-reported function was significantly pre-
dicted by each of the walk tests, with the TUG model
being the most predictive, explaining 55% of the vari-
ance. In regression modeling of total duration of physical
activity, TUG provided the only significant model,
explaining 36% of the variance.
Discussion
This study deepens our understanding of walking ability
of individuals one year after TKA surgery. The prevailing
norm in this area is to use short duration walk tests to
evaluate functional mobility after surgery [1,2,6-8]. It is
unclear whether such tests truly reflect ambulatory cap-
acity more typical of daily requirements in this popula-
tion. This study contributes to the existing literature on
both ambulation capacity after TKA and tests used to
measure capacity. For the first time, we have data which
provide comparisons between age-matched norms andCI), of TKA recipients and controls
TKA Controls Between group comparison, P
(6.3 to 9.0) 5.0 (4.2 to 6.0) <0.001
(380.1 to 466.8) 582.1 (559.9 to 604.2) <0.001
(1.07 to 1.29) 1.61 (1.55 to 1.67) <0.001
(1837 to 2381) 3086 (2981 to 3191) <0.001
(0.64 to 0.72) 0.81 (0.78 to 0.83) <0.001
(107 to 117) 124 (120 to 128) <0.001
(1.02 to 1.32) 1.71 (1.65 to 1.77) <0.001
rthroplasty.
Table 3 Repeatability of average distance (95% confidence interval), metres, walked during the first and second 30MW
test for TKA recipients and healthy controls
Test 1 Test 2 ICC
TKA (n=12) 2130.7 (1542.9 to 2718.5) 2209.8 (1678.5 to 2741.1) 0.97 (0.90 to 0.99)
Controls (n=43) 3085.9 (2981.1 to 3190.7) 3138.7 (3029.7 to 3247.7) 0.96 (0.91 to 0.98)
Average time between tests was 8 days.
Abbreviations:
30MW = 30 minute walk; ICC = Intraclass Correlation Coefficient; N = number; TKA = Total knee arthroplasty.
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minute period. Likewise, we now have confirmation that
the 6MW test is an excellent predictor of longer dur-
ation ambulation after TKA. Consequently, our study
provides long overdue construct validity for the use of
6MW test as a measure of functional ambulation in
TKA recipients [30]. Because of the close relationship
between the 6MW and 30MW tests, contrary to our ex-
pectations, the 30MW test did not demonstrate greater
capacity to differentiate between individuals nor have
stronger correlations with patient-reported outcomes
compared to the 6MW test. As such, an extended walk
test is no more useful as a research tool than the shorter
walk tests in this population and yet is more arduous.
We observed that the 30-minute walking capacity of
TKA recipients at one year after surgery remains signifi-
cantly inferior to their healthy counterparts. Given theFigure 1 Correlation between a) 30MWD (n = 32) and TUG
(n = 29, r = −0.82, P < 0.001; y = 6.10x – 472.01); b) 30MWD and
6MWD (n= 32, r = 0.97, P < 0.001; y = −230.3x + 3998.1).
30MWD = Thirty minute walk distance (meters); TUG = Timed up
and go (seconds); 6MWD = Six minute walk distance (meters).similar effort observed during the 30MW test between
TKA recipients and controls and the subjective
reporting by participants, the inferior performance is
likely explained by the presence of a prosthetic joint and
pain in the index joint, as well as other factors shown to
influence recovery such as the presence of significant
co-morbidities [31], severe other joint disease [18], and
obesity [18,28]. Lower physical activity levels reported by
the TKA cohort, which are a likely manifestation of the
co-morbidities, joint disease and obesity associated with
patients requiring TKA, may also be a contributing fac-
tor to their poorer performance. Despite their limita-
tions, all TKA recipients completed the test without
adverse events, indicating that though the test is ardu-
ous, it appears to be safe. The 30MW test was observed
to be highly repeatable. The healthy cohort walked sig-
nificantly further by 50 m in the second test. This differ-
ence may be due to a practice effect, which has been
described by some authors in the 6MW test [16]. It is
likely that a significant increase was not seen in the TKA
cohort because there was greater variability in their per-
formance, as indicated by a larger standard deviation of
the difference between the first and second test (TKA
SD 215 m vs Controls SD 93 m). The reluctance by pa-
tients to repeat the test reflects that it may not be em-
braced in this population, but this does not alter the
new insights gained about ambulatory capacity, the vari-
ous associations between the walk tests, or between the
walk tests and patient-reported outcomes.
The observed residual impairment in mobility amongst
our TKA cohort is further supported by comparisons be-
tween their 6MW test performance with published stand-
ard values of healthy elderly populations. Using the
reference equation published by Troosters et al. [16], our
healthy cohort performed very similarly to their predicted
distance (582 m vs predicted 576 m), while the perform-
ance of our TKA cohort was much lower than their pre-
dicted distance (424 m vs predicted 538 m). As this
reference equation takes into account age, gender, height
and weight (the constituents of BMI), it demonstrates that
the higher BMI of the TKA cohort only makes a minor
contribution to the large difference in walking perform-
ance compared to the healthy cohort. Using reference
equations published by Enright et al. [32], which have
been considered by some to underestimate normal




WOMAC function P Physical Activity P
Model 1 (n = 28) R2 = 0.55 <0.001 R2 = 0.36 0.01
BMI 0.67 (−1.27 to 2.61) 0.48 4.11 (−10.68 to 18.89) 0.57
Gender −14.23 (−34.93 to 6.47) 0.17 45.06 (−112.70 to 202.77) 0.56
TUG 6.58 (3.16 to 10.0) <0.001 −42.46 (−68.52 to −16.40) 0.003
Model 2 (n = 32) R2 = 0.34 0.01 R2 = 0.16 0.18
BMI 0.40 (−1.83 to 2.62) 0.72 3.14 (−12.64 to 18.92) 0.69
Gender −15.14 (−38.30 to 8.03) 0.19 14.23 (−150.10 to 178.51) 0.86
6MW distance −0.10 (−0.20 to −0.01) 0.04 0.67 (0.00 to 1.35) 0.05
Model 3 (n = 32) R2 = 0.34 0.01 R2 = 0.16 0.19
BMI 0.33 (−1.90 to 2.57) 0.76 3.44 (−12.47 to 19.34) 0.66
Gender −16.39 (−39.17 to 6.40) 0.15 23.39 (−138.89 to 185.64) 0.77
30MW distance −0.02 (−0.03 to −0.001) 0.04 0.10 (−0.02 to 0.21) 0.05
Abbreviations:
6MW = Six-minute walk; 30MW = 30-minute walk; BMI = Body mass index; CI = Confidence interval; N = number; TKA = Total knee arthroplasty; TUG = Timed Up
and Go; WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index.
Ko et al. BMC Musculoskeletal Disorders 2013, 14:145 Page 7 of 9
http://www.biomedcentral.com/1471-2474/14/145walking distance [10,33], the performance of our TKA co-
hort was still inferior, with the predicted distance for TKA
group of 464 m.
The near-perfect correlation between the 6MW and
30MW tests and the high predictability of 30MW distance
by 6MW distance were unexpected. This is because par-
ticipants were instructed to walk as far as possible but
safely, and as such we expected that some participants
would not be able to maintain the same speed in both
tests, presuming a comparatively poor fitness level in the
cohort. We observed that the healthy cohort walked faster
in the longer test. This may be due to less frequent decel-
eration and turning associated with the longer lap in the
30MW test. In contrast, the walking speeds of TKA recipi-
ents were identical in both tests. The gain in walk speed
associated with a longer track was not seen in the TKA
cohort, suggesting that the 30MW test was indeed more
fatiguing for this cohort. For some participants, the overall
walk speed was reduced as a result of the rests taken dur-
ing the 30MW test and these people demonstrated the
slowest speeds in the 6MW test. For those who did not
rest, there was a trend for a slightly faster speed but this
did not quite reach statistical significance. Consequently,
whilst fatigue likely did become a factor in the longer test,
its effects were small, and those most affected were those
who performed worst in the 6MW test anyway. Thus the
prediction of the 30MWD and 6MWD was high. The
knowledge that a strong correlation exists between the
6MW and 30MW tests is useful both in clinical practice
and research, as it means that the 6MW test is a suitable
tool to evaluate interventions aimed at improving longer
duration ambulation; specifically, the 6MW test will pre-
dict how far a TKA recipient can walk over 30 minutes
with acceptable accuracy.All three walk tests moderately predicted self-reported
function. The 6MW and 30MW tests produced similar
models for reasons described above, with TUG produ-
cing the strongest model. A possible explanation for the
latter is that, unlike the 30MW and 6MW tests, TUG
performance is a combination of walking ability, lower
limb strength and balance owing to the sit-to-stand
component, and is based on activities similar to items
included in the WOMAC questionnaire. Others have
found similar, modest relationships between measured
ambulation and self-reported function. Rossi et al. [11]
found moderate correlation between TUG and perceived
function amongst participants 17 months after TKA.
Another study examining short-term recovery also found
only moderate correlation between self-reported func-
tion and performance based outcomes [12]. Our results,
based on a cohort 1 to 1.5 years post-surgery, add to the
growing body of literature justifying the collection of
both performance-based and self-reported measures in
assessing longer-term recovery after TKA.
Physical activity levels reported by the TKA cohort were
significantly lower than the control group. The average
time spent performing physical activities by TKA recipi-
ents (202 minutes) was also lower than reported in a simi-
larly aged population-based sample (255 minutes) using
the same survey [26], whilst the activity levels of our
healthy cohort (mean 504 min) were much greater. Whilst
these comparisons with population-based data appear to
corroborate the representativeness of both our patient and
healthy cohorts in terms of self-reported physical activity,
we remain unclear as to the relationship between self-
reported physical activity and measured ambulation. TUG
was a significant, but weak predictor of self-reported phys-
ical activity in our TKA cohort. A possible explanation for
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by other factors such as self–efficacy [34], personality,
knowledge, beliefs and social support [35] and not just
physical mobility. Alternatively, patient-reported physical
activity may not reliably measure actual physical activity
[36]. It is not known how accurately the survey questions
we used correlate with actual performance. We used ques-
tions used by a large Australian population-based study -
the National Physical Activity Survey [26] - for the purposes
of having a population-based comparison. The trade-off for
this approach is the lack of certainty with which these ques-
tions do reliably reflect actual physical activity.
By virtue of our design, this study also describes for the
first time the spatio-temporal gait characteristics of TKA
recipients under natural environmental conditions, as gait
analysis in this population has mostly been conducted
from snap-shots created under laboratory conditions [37].
Whilst the shorter step length and lower cadence observed
compared to age-matched controls are consistent with
published data [38-40], the lower cadence in our TKA re-
cipients, compared to that observed during fast walking in
the laboratory amongst participants with similar charac-
teristics [37], may reflect the use of different strategies to
achieve fast walking in different environments. Further
study of gait parameters in natural walking environments
may give greater insight into the persistent walking limita-
tions in the TKA population.
A limitation to the study is that the results are limited
to the TKA population one year post-surgery. A minor
limitation of the study is the sample size of the TKA co-
hort as it necessarily restricted the number of variables
included in the regression modeling. A larger sample
would have allowed the inclusion of other potential pre-
dictors, such as age and co-morbidity which are known
predictors of the shorter walk tests [41-43]. This not-
withstanding, as 6MW distance was such a strong pre-
dictor of the 30MW distance, it is unlikely that inclusion
of other variables would change the definitive model
substantially. Furthermore, factors such as age, gender
and BMI are accounted for to some degree by their asso-
ciation with 6MW distance [41,42]. A potential limita-
tion of the study was that our TKA cohort included
TKA recipients with and without the common mobility-
limiting co-morbidities. A sample which excluded pa-
tients with significant co-morbidity would have enabled
a more straight-forward comparison between age-
matched peers and TKA recipients, and eliminate the
variability in walk tests due to factors other than the
TKA surgery. However, such a sample would not be rep-
resentative of typical TKA cohorts. We note that sub-
group analyses of TKA recipients with minimum
co-morbidities still demonstrated significantly inferior
performance compared to healthy controls. Not ran-
domizing the order of testing to eliminate the effect offatigue during testing could be viewed as another poten-
tial limitation in this study. However, the amount of time
required after the 30MW test to ensure sufficient rest
made this impractical. Furthermore, it was unlikely that
fatigue affected testing because amongst the TKA co-
hort, in whom fatigue would have a larger potential im-
pact, those who returned for a repeat 30MW test (which
did not follow a 6MW test) did not perform significantly
better in the second test.
Conclusions
The 30MW test highlights the persistent subnormal mo-
bility seen in this cohort, its utility, however, is lacking
as it does not provide greater predictive value for
patient-reported outcomes than the shorter walk tests
and the test appears particularly arduous. As the 30 MW
test is almost completely predicted by the 6MW test,
this study demonstrates that the 6MW test is a robust
measure of functional mobility in long-term recovery
amongst TKA recipients. Our findings reinforce the use
of performance-based tests such as the 6MW and TUG
tests together with self-report outcomes to evaluate re-
covery of functional mobility.
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